Manage stand orders
Select Option
Advertisement
THERICON GmbH
Cubex 41 Theodor-Kutzer-Ufer 1-3,
68167
Mannheim
Germany
Germany
This company is co-exhibitor of
MEDICA Start-up Park - Messe Düsseldorf GmbH
Location
Hall map
Fairground map
Our range of products
Product categories
- 01 Electromedical Equipment / Medical Technology
- 01.02 Imaging supplies
Imaging supplies
Our products
Product category: Imaging supplies
Multiparametric endoscopy systems
Based on a proprietary real-time multispectral imaging technology (rMSI), Thericon is developing revolutionary endoscopy visualization systems that combine in one device the most important and promising optical imaging technologies, including virtual chromoendoscopy and fluorescence imaging. Different functional and structural images presented simultaneously side-by-side or in various overlays will help surgeons recognize different structures, such as nerves, blood vessels, and malignant tissue, and inform treatment decisions. The unprecedented wealth of information also opens up huge potential for future developments, including AI-driven diagnosis.
Our devices provide a familiar interface and require no changes to surgical procedures.
The first application is in bladder cancer surgeries (transurethral resection of bladder tumor, TURBT).
Our devices provide a familiar interface and require no changes to surgical procedures.
The first application is in bladder cancer surgeries (transurethral resection of bladder tumor, TURBT).
About us
Company details
IMPROVING THE PROGNOSIS OF 550,000 PATIENTS DIAGNOSED WITH BLADDER CANCER EACH YEAR BY MAKING CANCER STAND OUT
Our mission is to improve the success of surgeries by enabling surgeons better to distinguish different tissue types and identify malignant lesions. Our proprietary technology enables multiparametric endoscopy where various structural and functional images are provided simultaneously.
The first application of our real-time multispectral imaging technology is in transurethral resections of bladder tumor (TURBT), where we expect it will contribute to reducing disease recurrence and minimizing collateral tissue damage.
Our mission is to improve the success of surgeries by enabling surgeons better to distinguish different tissue types and identify malignant lesions. Our proprietary technology enables multiparametric endoscopy where various structural and functional images are provided simultaneously.
The first application of our real-time multispectral imaging technology is in transurethral resections of bladder tumor (TURBT), where we expect it will contribute to reducing disease recurrence and minimizing collateral tissue damage.
Company data
Foundation2019
Area of businessElectromedical equipment / Medical Technology